Abstract. The promoter of the ornithine decarboxylase (ODC) gene contains two E-boxes, which are critical sites for transcriptional activation by the binding of c-Myc-Max heterodimers. We have identified heterogeneous nuclear ribonuclear protein U (hnRNP U) as a component of the complex formed on the E-box-containing promoter region of the ODC gene by using DNA-affinity chromatography, immunoprecipitation and chromatin immunoprecipitation assays. The N-terminal domain of hnRNP U was responsible for the association with c-Myc-Max complex. Down-regulation of hnRNP U with RNA interference blocked the induction of the ODC gene and cell growth by serum stimulation, suggesting that hnRNP U is a coactivator of the c-Myc-Max complex and essential for cell proliferation. Electrophoretic mobility-shift assays revealed that the segment between the two E-boxes in the promoter is the primary binding site of hnRNP U. The putative binding sequence was narroweddown to a 13-nucleotide segment by comparing the sequence between the E-boxes with the binding sites of hnRNP U, which were recently identified in the promoter of Bmal1, a core component of the circadian molecular oscillator. These findings increase our knowledge of how the c-Myc-Max complex exerts its transcriptional regulatory role and suggest that hnRNP U may be a coactivator of this transcriptional activator complex.
Introduction
Heterogeneous nuclear ribonucleoprotein U (hnRNP U) is enriched in the nuclear matrix and regulates gene transcription (1) (2) (3) . hnRNP U binds conserved AT-rich regions within the genome called scaffold attachment regions, which allow chromatin to attach to the nuclear matrix and form 5-200-kb loops (4) . hnRNP U was independently identified as a protein that binds to these scaffold attachment region elements and was termed scaffold attachment factor A (5).
The multifunctional properties of hnRNP U have been mapped to specific domains within the protein. The N-terminal domain (acidic and glutamine rich) is important for interactions with nuclear matrix and chromatin, and the C-terminal domain, which contains an RGG box, is important for interactions with other hnRNP proteins to form hnRNP particles (6, 7) . The middle domain mediates the interaction of hnRNP U with RNA polymerase II, and its association inhibits TFIIHmediated phosphorylation and RNA polymerase II elongation (8) .
Myc proteins are basic helix-loop-helix leucine-zipper (bHLH-Zip) transcription factors whose function relies on heterodimerization with Max through their related bHLH-Zip domain (9) . The Myc-Max heterodimer binds to E-box DNA sequences (CAYGTG) and can activate transcription through a tethered complex of proteins that contains histone acetyltransferase and other activities that remodel chromatin (10) . Max also heterodimerizes with other proteins that contain Myc-like bHLH-Zip domains, including the Mad family proteins Mxd 1-4, the Mad-related protein Mnt, and Mga (11, 12) . A current model proposes that E-boxes are occupied by Mnt-Max in quiescent cells, whereas Mnt-Max complexes are displaced by Myc-Max complexes in growth-stimulated cells (13, 14) .
Since we previously proposed possible higher-order interactions among c-Myc, Max, HDAC1 and Mnt that regulate the expression of Myc-target genes such as the ornithine decarboxylase (ODC) gene (15), we attempted to isolate other candidate molecules that might be involved in the regulation of gene expression by binding to the E-boxcontaining promoter region. During the study, we found interaction between hnRNP U and c-Myc-Max complexes, and a coactivator function of hnRNP U for c-Myc-Max transcriptional activator.
Materials and methods
DNA-affinity chromatography and mass spectrometry. Nuclear extracts of rat 3Y1 fibroblasts were prepared by using NE-PER nuclear and cytoplasmic extraction reagents (Pierce Biotechnology), according to the manufacturer's instructions. Extracts were pre-cleared by incubation with streptavidin magnetic beads (Takara Biotechnology, Ohtsu, Japan) in the presence of 50 ng/ml of salmon sperm DNA. The extracts (100 μg) were incubated with a biotin-labeled oligonucleotide consisting of 62 bps of the E-box-containing region of the ODC promoter (800 pmole) in 100 μl of binding solution (20 mM Tris-HCl pH 7.9, 60 mM KCl, 1 mM EDTA, 0.1% Triton X-100, 1 mM DTT, 10 μg/ml leupeptin) for 20 min at room temperature, and the protein-DNA complexes were collected by incubation with 100 μl of streptavidin magnetic beads for 1 h at 4˚C. After washing the beads 5 times with 1 ml of the binding solution, the bound proteins were eluted with 50 μl of elution buffer (20 mM Tris-HCl pH 6.8, 1 M NaCl, 1 mM EDTA, 1 mM DTT).
A band was excised from the silver stained gel, cut into pieces, washed twice with 200 μl of 50 mM NH 4 HCO 3 in 50% acetonitrile (v/v), and dehydrated with 100 μl of 100% acetonitrile. Reduction of the protein sample was achieved with 10 mM DTT/100 mM NH 4 HCO 3 at 56˚C for 1 h, and alkylation was performed with 55 mM iodoacetamide/100 mM NH 4 HCO 3 for 45 min in the dark at room temperature. Subsequently, the gel pieces were washed twice for 5 min alternatively with 100 mM ammonium carbonate and acetonitrile, and then the gel pieces were completely dried under reduced-pressure. Appropriate volumes of trypsin solution (25 μg/μl trypsin in 50 mM NH 4 HCO 3 ) were added to the dried gel pieces. After an overnight incubation at 37˚C, the supernatant containing digested peptides was transferred to a new centrifuge tube. The gel pieces were washed with 20 μl of 20 mM NH 4 HCO 3 and 20 μl of 50% (v/v) acetonitrile in 5% (v/v) formic acid. The peptide mixture was purified by using ZipTip pipette tips containing C18 reversed-phase material, according to the manufacturer's instructions. The eluted peptide solution was placed on a MALDI target plate, mixed with a matrix 2,5-dihydroxybenzoic acid (Sigma), and analyzed by a MALDI-Qq-TOF MS/MS QSTAR Pulsar i (Applied Biosystems) in the linear positive ion mode. The spectrum data were submitted for protein identification with peptide mass fingerprinting, and database searching was performed with MASCOT ver1.9 (Matrix Science) in NCBInr.
Plasmid construction and transfectoin. The cDNAs that encode the N-terminus (amino acids: 1-278), middle section (amino acids: 264-531), and C-terminus (amino acids: 532-800) of mouse hnRNP U were amplified from the RNA of NIH 3T3 cells by RT-PCR. The primer set for the N-terminus was 5'-TTCTGCAGAGTTCTTCGCCTGTTAATGT-3' (forward) and 5'-TGTCTCACAGTTGCATGTTTTTATT-3' (reverse). The primer set for the middle section was 5'-TCTGCAG GTTTGTCTTGATACTTATAATTG-3' (forward) and 5'-AA GTCGACCAACAGTGTGTTCAGTTTTCC-3' (reverse). The primer set for the C-terminus was 5'-TTCTGCAGCAGA GAGCCCCACAGT-3' (forward) and 5'-AGTCGACATA ATATCCTTGGTGATAATGC-3' (reverse). The forward primers contain PstI sites (underlined), and the reverse primers contain SalI sites (underlined). The RT-PCR products were cloned into the pTA2 vector (Toyobo, Osaka, Japan). To construct the cytomegalovirus expression vectors for deletion mutants after confirming the sequences, the Nterminus fragment was excised from the pTA2 vector with PstI and XhoI and inserted into the PstI/XhoI sites of the pCMV/myc/nuc vector (Invitrogen), which has a myc epitope tag and nuclear localization signal. Then, the XhoI site was blunted and re-ligated. The fragments for the middle section and the C-terminus of hnRNP U were excised with PstI and SalI and inserted into the same sites of the pCMV/myc/nuc vector. The expression vector for wild-type hnRNP U (amino acids: 1-800) was constructed by first inserting a carboxyl terminal-half fragment digested with PstI and SalI into the PstI/XhoI sites of the pCMV vector, followed by re-ligating the N-terminus fragment into the PstI/XhoI-cut sites of the first construct. Ten micrograms each of the empty vectors and expression vectors was used to transfect Cos-7 cells with Lipofectamine 2000 (Invitrogen).
Immunoprecipitation and immunoblot. Subconfluent cultures of NIH 3T3 fibroblasts were serum-starved for 3 days and then growth stimulated by adding serum for 3 h. Nuclear extracts (30 μg) were incubated with the indicated antibodies (2 μg each) in 50 μl of binding solution (20 mM Tris-HCl pH 7.9, 60 mM KCl, 1 mM EDTA, 0.1% Triton X-100, 1 mM DTT, 0.2 mg/ml bovine serum albumin, 10 μg/ml leupeptin) for 2 h at 4˚C. Then, the antigen-antibody complexes were collected by incubation with 5 μl of protein G magnetic bead suspension (New England Biolabs) for 1 h at room temperature and applied to a magnetic field for 5 min at 4˚C. Protein complexes were washed once with low-salt ChIP wash buffer (20 mM Tris-HCl pH 8.1, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1% SDS), twice with the high-salt wash buffer (500 mM NaCl), and once with TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA). Then, immunoprecipitates were resolved and probed with anti-hnRNP U (Bethyl Laboratories), anti-c-Myc (N-262; Santa Cruz) and anti-Max (C-124; Santa Cruz) rabbit polyclonal antibodies.
Nuclear extracts prepared from Cos-7 cells transfected with the expression vectors were immunoprecipitated with the anti-Myc epitope mouse monoclonal antibody. HnRNP U immunoprecipitations were resolved and probed with an antiMyc epitope mouse monoclonal antibody (PL14; Medical and Biological Laboratories, Nagoya, Japan), anti-c-Myc mouse monoclonal (9E10; Santa Cruz) and anti-Max rabbit polyclonal (C-124; Santa Cruz) antibodies.
RNA interference. A mixture of three short interfering RNA duplexes against mouse Hnrnpu (SASI_Mm01_00179155, SASI_Mm01_00179156, SASI_Mm01_00179157: Sigma Aldrich Japan) were applied by transfection at a final concentration of 10 nM each, and 30 nM of control short interfering RNA-A (Santa Cruz) was used as a control. Transfection of the short interfering RNAs was performed with TransIT-TKO transfection reagent (Mirus Bio), according to the manufacturer's protocol. After a 48-h transfection with hnRNP U and control short interfering RNAs, the cells were subjected to serum-starvation for 3 days and then restimulated for 6-36 h. Total cell lysates were subjected to immunoblot analysis with anti-hnRNP U (Bethyl Laboratories), anti-cMyc (N-262; Santa Cruz) and anti-Max (C-124; Santa Cruz) rabbit polyclonal antibodies, and anti-ß-actin mouse monoclonal (AC-15; Sigma) antibody. Actin was used as a loading control. RT-PCR was performed by using the following set of primers: ODC forward, 5'-CATCCAAAGGCAAAGT TGGT-3', reverse, 5'-AGCCACCACCAATATCAAGC-3'; ß-actin forward, 5'-CAGGGTGTGATGGTGGG-3', reverse, 5'-GGTCATCTTTTCACGGTTGG-3'. For cell proliferation assays, 1500 cells/well were replated in 96 well plates and counted at 18 and 36 h after serum stimulation using a 2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium (WST-8) reduction assay kit (Wako Pure Chemicals, Osaka, Japan) according to the manufacturer's protocol. Essentially the same data were obtained at both time points.
Electrophoretic mobility-shift assay. Nuclear extracts from the serum-stimulated NIH 3T3 cells were utilized. The binding reaction was performed in a volume of 20 μl consisting of 10 mM Tris-HCl pH 7.4, 50 mM potassium chloride, 2.5% glycerol, 1 mM EDTA, 5 mM Na 3 VO 4 , 1 μM okadaic acid (Wako Pure Chemical Industries, Osaka, Japan), 0.05% NP-40, and 50 ng poly(dI·dC) (Sigma-Aldrich Japan). Five hundred nanograms of 3T3 nuclear extract was added to the reaction mixture followed by 10-20 fmoles of a probe (sequence described below) that was biotin-labeled at the 3' ends of E-box1-inter. The DNA-binding reaction was allowed to proceed at room temperature for 30 min. The complexes were analyzed by electrophoresis through a 5% acrylamide nondenaturing gel in 50 mM Tris base, 50 mM borate, and 1 mM EDTA. The biotin-labeled probes were transferred to Amersham Hibond-N+ (GE Healthcare, UK) and detected with Chemiluminescent nucleic acid detection module (Pierce Biotechnology) according to manufacturer's instructions. When specified, a 200-fold molar excess of competitors was pre-incubated in the reaction mixture at room temperature for 30 min before adding the probe. The sequences of the competitors are: E-box1, 5'-TGTGCGGCCACGTGTCGCG AGG-3'; E-box2, 5'-GCAGGGGACACGTGGCCGGAGG-3'; E-box1-inter, 5'-TGTGCGGCCACGTGTCGCGAGGCCC GGACTGCGGTCGCCGGCAGG-3'; Inter-E-box2, 5'-CGA GGCCCGGACTGCGGTCGCCGGCAGGGGACACGTGG CCGGAGG-3; and Inter, 5'-CGAGG CCCGGACTGCGGT CGCCGGCAGG-3'. For supershift experiments, 2 μg of anti-hnRNP U (Bethyl Laboratories), anti-c-Myc (N-262; Santa Cruz) rabbit polyclonal antibodies or normal rabbit IgG (Upstate) were pre-incubated overnight at 4˚C followed by the addition of the probe.
Results

hnRNP U binds to E-box-containing promoter region of ODC gene.
Biotin-labeled sense and anti-sense oligonucleotides corresponding to the E-box region of the rat ODC gene were synthesized, annealed, and incubated with nuclear protein extracts prepared from rat (3Y1) or mouse (NIH 3T3) fibroblasts. E-box-bound proteins were recovered by incubation with avidin beads and eluted with 1 M NaCl. One of the most intense bands migrating at ~110 kDa (Fig. 1a) was excised, in-gel-digested with trypsin, and subjected to MALDI-TOF/MS analysis. Six peptide sequences were obtained and matched with rat hnRNP U (Fig. 1b) . Immunoblot analysis of 1 M NaCl eluates derived from mouse fibroblasts also showed binding of hnRNP U as well as HDAC1, c-Myc (Fig. 1c) , and Max (data not shown) to the E-box DNA.
Association of hnRNP U with c-Myc-Max complex is essential for ODC gene induction by growth stimulation.
Since binding of the c-Myc-Max complex to the E-box has a central role for ODC expression induced by growth stimuli, we initially analysed the interaction between hnRNP U and the c-MycMax complex under physiological condition. We used antihnRNP U antibody to immunoprecipitate proteins from nuclear extracts of 3T3 fibroblasts. Extracts from serum-stimulated cells contained greater amounts of c-Myc and Max compared with extracts from serum-starved cells (Fig. 2a) . Similar results were obtained by using anti-c-Myc antibody (Fig. 2a) . Chromatin immunoprecipitation experiments confirmed that more hnRNP U and c-Myc-Max complexes were bound to the E-box of the ODC gene after growth stimulation (data not shown).
To further test for function of hnRNP U in the regulation of the ODC gene through interaction with the c-Myc-Max complex, we used RNA interference to silence the hnRNP U gene. 3T3 cells were transfected with a mixture of three short interfering RNAs against target sequences on the hnRNP U gene. An almost complete and specific shut down of the gene resulting in very low endogenous hnRNP U expression was observed 36 h after transfection (Fig. 2b, upper panels) . 3T3 cells were then serum-starved for an additional 3 days and growth-stimulated for 6 h by adding serum. No induction of ODC was observed in the hnRNP U-silenced cells after addition of serum, whereas the expression of the gene was up-regulated in cells transfected with control short interfering RNAs (Fig. 2b, lower panels) . In addition, down-regulation of hnRNP U resulted in suppression of cell growth after the stimulation (Fig. 2c) . The protein levels of c-Myc and Max in the hnRNP U-silenced cells were unaffected (Fig. 2b , upper The N-terminal domain of hnRNP U is sufficient to mediate its association with c-Myc-Max complex. The multifunctional properties of hnRNP U have been mapped to specific domains within the protein (Fig. 3a) . To determine which domain of hnRNP U interacts with the c-Myc-Max complex, Myc epitope-tagged hnRNP U proteins were expressed in Cos-7 cells (Fig. 3b) . Nuclear extracts from Cos-7 cells transfected with the Myc epitope-tagged hnRNP U constructs were immunoprecipitated with the anti-Myc epitope antibody and probed by immunoblot with the anti-c-Myc or the anti-Max antibodies. Full-length and N-terminal domain hnRNP U proteins were co-immunoprecipitated with c-Myc and Max, demonstrating that the N-terminal domain is sufficient to mediate the interaction of hnRNP U with the c-Myc-Max complex (Fig. 3c) . We are currently investigating which domains of c-Myc and/or Max interact with the N-terminal domain and whether c-Myc-Max heterodimerization is needed for the interaction.
Interaction between hnRNP U and c-Myc-Max complex on E-box-containing promoter region.
We performed electrophoretic mobility-shift assays to narrow down the binding region for hnRNP U in the ODC promoter. Two shifted bands were observed when DNA fragments containing the first E-box and 31 bps of the area between the E-boxes were used as a probe ( Fig. 4a and b) . Supershift assays with anti-hnRNP U and anti-c-Myc antibodies revealed that the upper and lower bands corresponded to c-Myc-Max and hnRNP U-containing complexes, respectively (Fig. 4b) . The lower band was specifically abolished in the presence of competitor fragments containing the area between the two E-boxes.
DNA fragments containing the inner part and either one of the E-boxes interfered with the formation of both c-MycMax and hnRNP U-containing complexes. Interestingly, each of the E-box fragments somewhat diminished the formation of hnRNP U-containing complexes (the first E-box fragment had a stronger effect), in addition to completely inhibiting the binding of c-Myc-Max complexes to the probe (Fig. 4b) . Moreover, decreased intensities for the upper and lower bands in the supershift assays using anti-hnRNP U and antic-Myc antibodies, respectively, were obvious although single major shifted-bands were only observed in each sample (Fig. 4b) . Thus, hnRNP U may mainly contact the segment between the E-boxes, with an additional weaker interaction to the first E-box probably through association with the c-MycMax complex.
The rigid structure at the E-box-flanking region might not be the nuclear matrix because the region is composed of GC-rich sequences, whereas the DNA regions that anchor chromosomal DNA to the nuclear matrix are usually AT rich (16) . Binding of hnRNP U to GC-rich sequences is not exceptional for the ODC promoter since the GC-rich region (nucleotides -27 to +266) in the Bmal1 promoter was recently identified as the binding site of hnRNP U, binding of which is responsible for circadian expression of the gene (17) . Comparison of these promoter regions revealed a 13-nucleotide segment of the putative hnRNP U-binding sequence, GGACTGCRRTCGC (Fig. 4c) . This stretch corresponds to +251 to +263 of the Bmal1 promoter that is included in one of the four important sites identified for hnRNP U binding (17) .
Discussion
In the present study, we show that hnRNP U physically (Figs. 2 and 3 ) and functionally (Fig. 2) interacts with the c-Myc-Max complex. hnRNP U interacts with transcription factors including RNA polymerase II (2), TFII H (8), and WT1 (3) as well as histone acetyltransferases (18, 19) . On the other hand, c-Myc controls RNA polymerase II-and IIIregulated gene transcription (20, 21) . Furthermore, reciprocal interactions between c-Myc-Max complex and histone acetyltransferases (22, 23) and between Mxds/Mnt-Max complex and histone deacetylases (13, 14) have been established. Therefore, it is not surprising that hnRNP U and the c-MycMax complex interact on the E-box-containing region of the ODC promoter.
This study provides the first direct evidence to connect the Myc-regulated proliferation pathway and a molecule, hnRNP U, involved in the circadian molecular oscillator. In this regard, it is intriguing that the Clock-Bmal1 heterodimer, the positive loop of the circadian clock, binds to E-box and E-box-like enhancer sequences to mediate the transcription of certain genes in cooperation with Myc family proteins (24, 25) . Nevertheless, the association of hnRNP U with the c-Myc-Max complex is essential for ODC gene induction by growth stimulation (Fig. 2) . HnRNP U might be a component of another cascade that integrates the circadian clock with cell cycle regulation and tumorigenesis, which is a rapidly growing area of research.
